Anne DeGheest. Unicorns vs. Unicorpse = Business Models.
Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.
Glen Tullman is Chairman and Chief Executive Officer of Livongo Health™. Tullman is also a successful entrepreneur and co-founder and Managing Partner of 7wire Ventures, a Chicago-based investment firm focused on healthcare and education. Tullman most recently served as Chief Executive Officer of Allscripts (NASDAQ: MDRX), the leading global provider of Electronic Health Records, Practice Management and Electronic Prescribing systems. He led Allscripts’ IPO and secondary offerings. Under his leadership, revenues grew from $30 million in 1997 to more than $1.4 billion in 2012. Tullman stepped down in December 2012.
Prior to joining Allscripts, Tullman was CEO of Enterprise Systems, a leading healthcare-information services company providing resource-management solutions to large, integrated healthcare networks. Tullman led its IPO and secondary offerings. Enterprise was sold to McKesson HBOC (NYSE: MCK).
Jeffrey Margolis thoughts on the HealthTech funding world.
Jeff Margolis is widely recognized as a healthcare IT entrepreneur and innovator based on his 30-year track record of successfully applying technologies to address the complex problems facing the healthcare industry. Leveraging his deep systematic understanding of healthcare and groundbreaking architectural and integration methodologies, Jeff has built some of the nation’s largest and most innovative healthcare technology and service organizations.
Jeff is currently Chairman and CEO of Welltok, Inc., where he is driving the transformation of our current sickcare system to one of optimized health. Prior to Welltok, Jeff founded TriZetto, the first industry vertical SaaS enterprise solution, and originated the concept of Integrated Healthcare Management. During his tenure as Chairman and CEO, Jeff led TriZetto through a successful IPO and $1.4B private equity buyout.
Amir Dan Rubin serves as President and CEO of Stanford Health Care, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. With an operating budget of $2.7 Billion and an affiliation with Stanford University, Stanford Health Care provides leading edge and coordinated care across its growing healthcare system.Read full bio →
Rich Roth leads Dignity Health's innovation efforts, which seek to create and test novel services, programs, partnerships, and/or technologies – from within and outside of healthcare – that challenge the status quo and have the potential to reduce the cost of care, improve quality, and/or increase access to services. Working in concert with Dignity Health employees and physicians, Roth works to anticipate emerging trends and technologies with the goal of incubating, studying, and scaling efforts to improve care. Dignity Health's current focus is in the areas of mobile care and sensor based technology. Roth holds a Master's degree in Healthcare Administration from the University of Minnesota and a Bachelors degree in Public Health from West Chester University. He regularly advises venture capital organizations, and is on the Board of Ascension Health Ventures. In 2012, he was recognized by CHAUSA as one of the most promising leaders under 40 in healthcare.
Dr. Molly Joel Coye is Social Entrepreneur in Residence for the Network for Excellence in Health Innovation (NEHI), a nonprofit national health policy institute focused on enabling innovations that provide solutions to the most pressing issues facing our health care system today. From 2010 – 2015, Dr. Coye was the Chief Innovation Officer for UCLA Health and headed the Institute for Innovation in Health and the Global Lab for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Today the Global Lab for Innovation advances the exchange of health delivery innovations that enable dramatic improvements in access to and affordability of health services. Dr. Coye also advises technology developers, investors, national health systems and policy makers about disruptive technologies and business models that accelerate transformation and constrain health expenditures.Read full bio →
Dr. Rhee serves as Chief Health Officer and Vice President of IBM, where he has direct global responsibilities for all IBM integrated health services strategy, design and operations, which include key support and leadership of business development and corporate citizenship opportunities in health and healthcare. Prior to joining IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. While at HRSA, he served on and led numerous national initiatives related to prevention, quality, and public health. Dr. Rhee also served as the Director of the Office of Innovation and Program Coordination at the National Institutes of Health (NIH), which is the primary federal agency for research. While at NIH, he served on and led numerous initiatives related to eliminating health disparities and promoting health equity.Read full bio →
Dr. Rusty Hofmann, from Stanford Health, co-founded Grand Rounds with the goal of ensuring access to state-of-the-art care to everyone, everywhere. A few years ago, his son, Grady, became extremely ill and almost died. Dr. Hofmann was able to get an expert opinion from the country’s leading pediatric gastroenterologists on Grady’s diagnosis and treatment, which ultimately saved his life. With his “insider status,” Dr. Hofmann had access to the world’s greatest medical minds. Founded in 2011, Grand Rounds was born out of Dr. Hofmann’s vision to make all health care consumers “medical insiders.” The Grand Rounds solution helps restore individual health and quality of life, and benefits employers by facilitating decreased health care cost and increased employee productivity.Read full bio →
Brian is president and CEO of the National Business Group on Health, the nation's only non-profit organization devoted exclusively to representing large employers' perspective on national health policy issues and helping companies optimize business performance through health improvement and health care management. The Business Group leads initiatives to address the most relevant health care issues facing employers today and enables human resource and benefit leaders to learn, share and leverage best practices for improving health and controlling health care costs from the most progressive companies. Business Group members, which include 71 Fortune 100 companies and 426 companies in total, provide health coverage for more than 50 million U.S. workers, retirees and their families.Read full bio →
Ravi Hariprasad. Is Digital Mental Health Finally Here
As a board-certified, Harvard-educated physician, Dr. Hariprasad is a rare psychiatrist with a foundation in engineering and technology innovation. With an entrepreneurial background and practical experience on the bleeding edge of data science, he understands both the need and challenge present in optimizing clinical workflows with technology. Before earning a Doctorate of Medicine from the University of Pennsylvania and a Master of Public Health from Harvard University, Dr. Hariprasad attained a Bachelor of Science in Operations Research Engineering from Cornell University. In addition, Dr. Hariprasad completed his Psychiatry Residency at Massachusetts General Hospital, Harvard Medical School’s flagship teaching hospital.Read full bio →
Eve is the CEO & Co-Founder of Empower Interactive, Inc., a leader in digital behavioral health solutions. She is an experienced Silicon Valley product builder, entrepreneur and investor with expertise in assembling diverse teams to solve hard problems. Eve started her career as a product manager at Trilogy, an enterprise e-commerce software company, working on new ventures. From there, Eve held product, strategy and business development roles in software and internet businesses including Microsoft, Zazzle and eCert. Eve has also been a member of the investment teams at Amadeus Capital Partners, Vector Capital, and Greylock Partners. Prior to co-founding Empower, Eve was a Research Affiliate in the Synthetic Neurobiology Group at the MIT Media Lab. Eve holds an MBA from Stanford University and an SB and an M.Eng in Computer Science from the Massachusetts Institute of Technology.
Seth Feuerstein is a psychiatrist, entrepreneur and technology executive responsible for driving technology innovation within Magellan’s computerized cognitive behavioral therapy platform and programs. This portfolio is the leading behavioral change and engagement software suite used by millions of individuals throughout the U.S., U.K. and other health systems. Awarded the TripleTree iAward for Connected Health in the area of “Clinical Effectiveness,” this software was developed by Feuerstein’s team at Cobalt Therapeutics, a company he started and where he served as CEO until the company was acquired by Magellan in 2014.Read full bio →
Alon Matas founded BetterHelp, the world's largest e-counseling platform. With BetterHelp, anyone facing life's challenges can have an easy, affordable, and private access to a licensed and certified therapist. BetterHelp's members get professional counseling using their computer, tablet or mobile phone, anytime they need, anywhere they are. In 2015 BetterHelp was acquired by Teladoc (NYSE: TDOC), the nation's first and largest telehealth provider.
Prior to BetterHelp, Alon was the Founder and CEO of three startups in the consumer web space, leading them through their entire life cycles: conceptualizing, planning, fundraising, team building, product design, development, launch, iteration, commercialization, optimization, growth, and eventually M&A.
Alon is an advocate, advisor and mentor for ventures and ideas that use tech-based innovations to improve quality of life.
Morris is an active voice in enterprise and cloud software focused on the services and healthcare verticals. He has served as the Chair of the Software and Information Industry Association and is a frequent contributor to business, healthcare and technology forums and publications including Forbes, Washington Post, HITECH Answers, and Becker’s Hospital Review. Morris has a BA from Yale University and a JD from Harvard. Prior to DICOM Grid, Morris built and sold an industry-leading business process software company, OpenAir, to NetSuite (NYSE:N). Today, Morris leads DICOM Grid in its mission to build the next generation diagnostic imaging platform and enable higher quality, more cost effective healthcare.
Dr. Friese is an interventional radiologist at Mayo Clinic in Rochester, Minnesota. His clinical and research focus includes minimally invasive vascular disease and cancer. He serves as Medical Director for New Ventures and Business Development in the Center for Individualized Medicine and as Associate Chair of Finance in the Department of Radiology. He is past chair of Novation’s imaging council and currently sits on the cardiovascular council. Dr. Friese is co-founder of Evidentia Health (a seed-stage HIT company), an active angel investor, and board member for SV Biosystems, Inc. He earned an M.D. from Mayo Medical School and an M.B.A. from Harvard Business School where he collaborated with Professors Clay Christensen and Michael Porter.
David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.Read full bio →
Dr. Rideout was recently appointed as President and CEO of the Integrated Healthcare Association. The Integrated Healthcare Association is a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. Dr. Rideout also serves as a Senior Advisor to GE Ventures, focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University and University of California Berkeley Haas School of Business, teaching on topics related to healthcare technology, services and investment.Read full bio →
Sam Glick is a Partner in Oliver Wyman’s Health and Life Sciences practice, and the San Francisco Office Leader. He focuses on consumer-centric healthcare, working with leading providers, health plans, employers, enablement companies, retailers, and venture capital firms to find innovative, engaging ways to bend trend. He is an author of several recent Oliver Wyman points of view, including A Billion-Dollar Decision: Charting a New Course for US Healthcare Benefits and Private Exchanges Change the Game. Sam also leads many of Oliver Wyman’s healthcare commercialization research and intellectual capital development efforts.Read full bio →
Thomas J. Van Gilder, MD, JD, MPH, chief medical officer and vice president of informatics and analytics, is a board-certified physician in internal medicine, general preventive medicine and public health. Prior to joining Transcend Insights, he held several positions at Humana including a position as the national medical director for wellness.
Before Humana, Dr. Van Gilder served as the medical director for quality initiatives and as a practicing primary care physician for QuadMed, an organization that directs on-site medical facilities for a number of companies. He also served over nine years in the U.S. Public Health Service at the Centers for Disease Control and Prevention.
Ian is the CEO and co-founder of Augmedix. He's always been passionate about the intersection of science, engineering, and medicine which drew him to study Biomedical Engineering at Duke Unversity and complete his MBA at Stanford University. Ian has worked in several lifesciences and medical companies such as Intuitive Surgical, MC10, Edwards Lifesciences, and PixelOptics. Late in the summer of 2012, Ian had the rare opportunity to try an early version of Google Glass. He was inspired by the potential that he saw for Glass in healthcare, and dropped everything to found Augmedix, the first Google Glass startup.
Dr. Teresa Nauenberg MD is the division head for primary care at the Palo Alto Medical Foundation in Palo Alto, California, where she has been practicing medicine for the last 15 years. She received her medical degree from the University of California, San Francisco and trained at the University of California, Davis. Prior to becoming a physician, Dr. Nauenberg worked as a mechanical engineer for Hewlett Packard. Dr. Nauenberg is married and has two children; she enjoys skiing, gardening and traveling.
Chris has devoted his career to converting deep consumer insights into commercial value. He began his career in product management at Johnson & Johnson, where he rose quickly to run the $1B TYLENOL franchise, before starting his own marketing services business in 1998, called Rosetta. Chris and his team built Rosetta over the subsequent 13 years to be the largest privately held digital marketing agency in the world, before they sold it to the Publicis Groupe for a record price in 2011.Read full bio →
Derek Newell. Jiff CEO's View on Employers Driving Healthcare Changes
For 20 years, Derek has been leading innovative health technology and service companies. He led the company that built the first FDA-approved internet connected medical device and grew it into the world’s largest remote patient monitoring company. Before that, at LifeMasters, he helped pioneer the first patient-centric disease management platform and built one of the largest disease management companies in the US. Derek holds graduate degrees in business and public health from UC Berkeley.
Adam Jackson's view on patient engagement personalization
Adam Jackson is a technology entrepreneur obsessed with creating beautiful and easy to use products for both mobile and desktop web interfaces.
He is currently CEO and co-founder of Doctor On Demand, a healthcare service that provides Video Visits with board-certified physicians and psychologists via smartphones, tablets, and desktop computers. Patients simply download the Doctor On Demand app on a smartphone or tablet or visit www.doctorondemand.com on their desktop computer, provide a list of their symptoms, and are instantly connected to a provider licensed in their state for a video visit. Doctor On Demand delivers services through employers, health systems, health plans, and directly to consumers.
C. Andy Schuetz, PhD is a Sr. Data Scientist in Sutter Health’s Research Development & Dissemination group. Prior to Sutter Health, Andy managed the early development of the Evalytica cloud-based pharmacovigilance solution for Evidera. At Archimedes, he led the development of the ARCHeS SaaS product suite that leveraged the Archimedes model to improve the quality and efficiency of healthcare. Andy has nine years of experience in the healthcare analytics and medical device space. His research has focused on improving care for patients with type 2 diabetes and cardiovascular disease. He has authored publications in high impact journals such as Health Affairs and PLOS ONE, and has spoken at conferences such as Health Datapalooza and the Society for Medical Decision Making Annual Meeting. He received his PhD and BS in mechanical engineering from the University of California at Berkeley.
Dr. Levy brings more than 30 years of senior operational leadership and experience in the medical device industry. Prior to Chrono Therapeutics, he was the founding CEO of Incline Therapeutics that was acquired by The Medicines Company in January 2013 for up to $390 million.Read full bio →
Sean Duffy is the co-founder and CEO of Omada Health, one of Fast Company’s "50 Most Innovative Companies in the World." Omada Health is a digital health company dedicated to inspiring and empowering people everywhere to live free of chronic disease. The company’s flagship product, Prevent, is a 16-week, CDC-recognized program that lowers participants’ risk for obesity-related chronic disease using cutting-edge technology, world-class design, and the power of social networks.
An in-demand speaker and thought leader, Sean's accolades include a spot on The San Francisco Business Times’ 2015 list of "40 Under 40," J.P. Morgan's list of the "100 Most Intriguing Entrepreneurs of 2014,” and Diabetes Forecast magazine's list of "2014 Diabetes All Stars.”
Rick Altinger serves as Glooko’s first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Altinger helped launch the healthcare division’s provider services and drove Intuit’s acquisition of Medfusion in 2010. He also spearheaded Intuit Health’s growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko’s diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter, pump, CGM or mobile device type.
18 years at McKinsey & Company (7 as a partner, 6 as a senior partner/director). Led the Manufacturing and Service Operations practices in the US and the Asia-Pacific region. Led large-scale operational improvement programs at major corporations across multiple sectors including healthcare, technology, retail and financial services. On the faculty of the Continuing Studies program at Stanford University and the MBA program at the Haas School of Business at UC Berkeley. Holds an MBA from Stanford University, an MS in Computer Science from Georgia Tech, and a BTech in Electrical Engineering from IIT Bombay.
Dr. Sridhar (“Sri”) Seshadri joined Stanford Health Care (SHC) in July 2003 and is currently the Vice President for the Cancer and Cardiovascular service lines. Dr. Seshadri previously oversaw the hospital’s process excellence activities and in this role was responsible for improving the patient experience and increasing operational efficiencies across the hospital and the clinics. He is also responsible for the creation of the SHC Leadership Academy whose objective is to develop a cadre of empowered leaders to help SHC achieve its long term objectives. In his current role, he is responsible for the design and implementation of coordinated complex-care delivery across two of SHC’s strategic service lines. In order to fully leverage the research and development potential in the cancer service line, Dr. Seshadri is a member of the Executive Committees of the Stanford Cancer Institute.Read full bio →
Jack Young thoughts on the HealthTech funding world.
Jack heads up the Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was ranked as one of the most active venture investors in digital health. He is also a fund manager at dRx Capital, a Novartis and Qualcomm joint investment company. His investment interests are focused on the intersection of healthcare products and services and digital/wireless technologies. Jack’s current digital health investments include: Airstrip, AliveCor, ClearCare, Doctor On Demand, goBalto, Telcare and Welltok. Prior investments include: Validity (acquired by Synaptics), and Fitbit (NYSE: FIT).Read full bio →
Renee Compton Ryan, Vice President, Venture Investments, joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co.
Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.
With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).
Tom Rodgers is the Senior Vice President and Managing Director leading McKesson Ventures. He spent more than a decade in health care venture capital, most recently leading strategic investing efforts for Cambia Health, and before that as a Partner with Advanced Technology Ventures.Read full bio →
October 27, 2015
Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.
As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.
Robin Cisneros provides strategic direction and oversight of Kaiser Permanente’s new medical product and technology assessment and selection processes. For more than 25 years, Robin has been developing and leading the organization’s evidence-based, physician-led resources that assess, select, and purchase medical products and technology. This includes directing a complex, national network of clinical and business leaders, serving on several national KP initiatives, while aligning resources and clinical leadership to support large scale projects that deliver increasing value to patients and KP.
Darren Dworkin is Senior Vice President of Enterprise Information Systems and Chief Information Officer of the CedarsSinai Health System in Los Angeles, California. Additionally, Mr. Dworkin is the co-founder of Stanson Health and a managing director of Summation Health Ventures. Mr. Dworkin has spent over 20 years in information technology and over 12 in healthcare.
At Cedars-Sinai he has led the implementation of a comprehensive electronic medical record to help transform care through the use of advanced technology. Day to day Mr. Dworkin leads the strategy and technology operations of both the information and clinical technology teams.
Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.Read full bio →
Noah Lewis specializes in healthcare IT, digital health, clinical services and medtech investments across high growth company lifecycle stages—from series A to growth equity. His investing focuses on solutions that enable the transition to value-based care, dramatically reduce health system costs and improve patient outcomes. Prior to entering venture capital, Noah led corporate strategy for the $10B GE Healthcare Systems division where he previously led growth-focused marketing and product management initiatives. Noah started his 20 year operating career in the technology industry at IBM where he pioneered SaaS, cloud computing and e-commerce solutions. Noah holds a Masters degree from MIT and a Bachelors of Science degree from Skidmore College.
Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.Read full bio →
Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.
David Benshoof Klein is a healthcare investor and entrepreneur with over 14 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein cofounded Click Therapeutics which focuses on engineering, validating and commercializing Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. He formerly served as Managing Director at a life science asset management firm, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein is an avid art enthusiast and is co‐founder and owner of Klein Sun Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China. A native New Yorker, Mr. Klein has been a guest lecturer at Columbia University’s Biotechnology Program, and holds a B.A. from Brandeis University.
Ian Edvalson is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto and San Diego offices. He assists private and public companies in creating and implementing strategies to optimize their technology and other assets, advising them on a variety of legal and business issues. Ian represents clients in domestic and international transactions involving intellectual property or product rights, such as collaboration, development, manufacture, supply and distribution agreements, technology acquisitions, university licenses, and the formation of joint ventures and other types of strategic alliances. Ian has a wide variety of business and legal experience covering a full range of issues and transactions facing technology companies, particularly in the biopharmaceutical and life sciences industries. He works closely with his clients in setting strategic direction and structuring and negotiating mission-critical business arrangements.Read full bio →
Kit Sun is the Founder and CEO of NavisHealth, and is responsible for the company’s day-to-day operations. Sun oversaw the growth of the company since the inception and has led the successful launch of the company’s flagship healthcare analytics products and the mobile patient engagement solutions. Prior to NavisHealth, Sun served as a management consultant specialized in Health IT operations in the Provider industry. Previously, Sun spent 7 years at Autodesk where he held multiple management roles including International business development, Emerging product management and SaaS business operations. Sun holds a Bachelor of Science degree in Electrical and Computer Engineering from University of Wisconsin, Madison.
As chief strategy officer for Healthline Networks, Murray Brozinsky heads business and corporate development for the company – including its consumer subsidiary, Healthline.com, and its enterprise technology subsidiary, Talix. He has more than 20 years of experience founding, operating and advising high growth technology firms. Murray has spoken at numerous industry conferences on various health information technology topics and trends. He holds a B.S. in Finance and a B.A. in Philosophy from the University of Pennsylvania, an M.S. in Engineering from Northwestern University’s McCormick School of Engineering and Applied Science, as well as an M.B.A. from Northwestern University's Kellogg and McCormick schools. Murray also sits on the board and/or advisory board of numerous tech start-ups.